185 related articles for article (PubMed ID: 37086482)
1. SARM1 deletion delays cerebellar but not spinal cord degeneration in an enhanced mouse model of SPG7 deficiency.
Montoro-Gámez C; Nolte H; Molinié T; Evangelista G; Tröder SE; Barth E; Popovic M; Trifunovic A; Zevnik B; Langer T; Rugarli EI
Brain; 2023 Oct; 146(10):4117-4131. PubMed ID: 37086482
[TBL] [Abstract][Full Text] [Related]
2. Alternative splicing of Spg7, a gene involved in hereditary spastic paraplegia, encodes a variant of paraplegin targeted to the endoplasmic reticulum.
Mancuso G; Barth E; Crivello P; Rugarli EI
PLoS One; 2012; 7(5):e36337. PubMed ID: 22563492
[TBL] [Abstract][Full Text] [Related]
3. Axonal degeneration in paraplegin-deficient mice is associated with abnormal mitochondria and impairment of axonal transport.
Ferreirinha F; Quattrini A; Pirozzi M; Valsecchi V; Dina G; Broccoli V; Auricchio A; Piemonte F; Tozzi G; Gaeta L; Casari G; Ballabio A; Rugarli EI
J Clin Invest; 2004 Jan; 113(2):231-42. PubMed ID: 14722615
[TBL] [Abstract][Full Text] [Related]
4. Impaired flickering of the permeability transition pore causes SPG7 spastic paraplegia.
Sambri I; Massa F; Gullo F; Meneghini S; Cassina L; Carraro M; Dina G; Quattrini A; Patanella L; Carissimo A; Iuliano A; Santorelli F; Codazzi F; Grohovaz F; Bernardi P; Becchetti A; Casari G
EBioMedicine; 2020 Nov; 61():103050. PubMed ID: 33045469
[TBL] [Abstract][Full Text] [Related]
5. Spastic paraplegia gene 7 in patients with spasticity and/or optic neuropathy.
Klebe S; Depienne C; Gerber S; Challe G; Anheim M; Charles P; Fedirko E; Lejeune E; Cottineau J; Brusco A; Dollfus H; Chinnery PF; Mancini C; Ferrer X; Sole G; Destée A; Mayer JM; Fontaine B; de Seze J; Clanet M; Ollagnon E; Busson P; Cazeneuve C; Stevanin G; Kaplan J; Rozet JM; Brice A; Durr A
Brain; 2012 Oct; 135(Pt 10):2980-93. PubMed ID: 23065789
[TBL] [Abstract][Full Text] [Related]
6. Genotype-phenotype correlations in spastic paraplegia type 7: a study in a large Dutch cohort.
van Gassen KL; van der Heijden CD; de Bot ST; den Dunnen WF; van den Berg LH; Verschuuren-Bemelmans CC; Kremer HP; Veldink JH; Kamsteeg EJ; Scheffer H; van de Warrenburg BP
Brain; 2012 Oct; 135(Pt 10):2994-3004. PubMed ID: 22964162
[TBL] [Abstract][Full Text] [Related]
7. SARM1 is a metabolic sensor activated by an increased NMN/NAD
Figley MD; Gu W; Nanson JD; Shi Y; Sasaki Y; Cunnea K; Malde AK; Jia X; Luo Z; Saikot FK; Mosaiab T; Masic V; Holt S; Hartley-Tassell L; McGuinness HY; Manik MK; Bosanac T; Landsberg MJ; Kerry PS; Mobli M; Hughes RO; Milbrandt J; Kobe B; DiAntonio A; Ve T
Neuron; 2021 Apr; 109(7):1118-1136.e11. PubMed ID: 33657413
[TBL] [Abstract][Full Text] [Related]
8. The SARM1 Toll/Interleukin-1 Receptor Domain Possesses Intrinsic NAD
Essuman K; Summers DW; Sasaki Y; Mao X; DiAntonio A; Milbrandt J
Neuron; 2017 Mar; 93(6):1334-1343.e5. PubMed ID: 28334607
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial impairment activates the Wallerian pathway through depletion of NMNAT2 leading to SARM1-dependent axon degeneration.
Loreto A; Hill CS; Hewitt VL; Orsomando G; Angeletti C; Gilley J; Lucci C; Sanchez-Martinez A; Whitworth AJ; Conforti L; Dajas-Bailador F; Coleman MP
Neurobiol Dis; 2020 Feb; 134():104678. PubMed ID: 31740269
[TBL] [Abstract][Full Text] [Related]
10. Prevention of vincristine-induced peripheral neuropathy by genetic deletion of SARM1 in mice.
Geisler S; Doan RA; Strickland A; Huang X; Milbrandt J; DiAntonio A
Brain; 2016 Dec; 139(Pt 12):3092-3108. PubMed ID: 27797810
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel compound heterozygous SPG7 mutations-related hereditary spastic paraplegia in a Chinese family: a case report.
Zhang X; Zhang L; Wu Y; Li G; Chen S; Xia Y; Li H
BMC Neurol; 2018 Nov; 18(1):196. PubMed ID: 30497413
[TBL] [Abstract][Full Text] [Related]
12. Abnormal Paraplegin Expression in Swollen Neurites, τ- and α-Synuclein Pathology in a Case of Hereditary Spastic Paraplegia SPG7 with an Ala510Val Mutation.
Thal DR; Züchner S; Gierer S; Schulte C; Schöls L; Schüle R; Synofzik M
Int J Mol Sci; 2015 Oct; 16(10):25050-66. PubMed ID: 26506339
[TBL] [Abstract][Full Text] [Related]
13. cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy, compromised, and degenerating axons.
Sasaki Y; Engber TM; Hughes RO; Figley MD; Wu T; Bosanac T; Devraj R; Milbrandt J; Krauss R; DiAntonio A
Exp Neurol; 2020 Jul; 329():113252. PubMed ID: 32087251
[TBL] [Abstract][Full Text] [Related]
14. Traumatic axonopathy in spinal tracts after impact acceleration head injury: Ultrastructural observations and evidence of SARM1-dependent axonal degeneration.
Alexandris AS; Lee Y; Lehar M; Alam Z; Samineni P; Tripathi SJ; Ryu J; Koliatsos VE
Exp Neurol; 2023 Jan; 359():114252. PubMed ID: 36244414
[TBL] [Abstract][Full Text] [Related]
15. Genetic interaction between the m-AAA protease isoenzymes reveals novel roles in cerebellar degeneration.
Martinelli P; La Mattina V; Bernacchia A; Magnoni R; Cerri F; Cox G; Quattrini A; Casari G; Rugarli EI
Hum Mol Genet; 2009 Jun; 18(11):2001-13. PubMed ID: 19289403
[TBL] [Abstract][Full Text] [Related]
16. Expanding SPG7 dominant optic atrophy phenotype: Infantile nystagmus and optic atrophy without spastic paraplegia.
Seo Y; Lim HT; Lee BJ; Han J
Am J Med Genet A; 2023 Feb; 191(2):582-585. PubMed ID: 36367250
[TBL] [Abstract][Full Text] [Related]
17. Variable and tissue-specific subunit composition of mitochondrial m-AAA protease complexes linked to hereditary spastic paraplegia.
Koppen M; Metodiev MD; Casari G; Rugarli EI; Langer T
Mol Cell Biol; 2007 Jan; 27(2):758-67. PubMed ID: 17101804
[TBL] [Abstract][Full Text] [Related]
18. Nicotinic acid mononucleotide is an allosteric SARM1 inhibitor promoting axonal protection.
Sasaki Y; Zhu J; Shi Y; Gu W; Kobe B; Ve T; DiAntonio A; Milbrandt J
Exp Neurol; 2021 Nov; 345():113842. PubMed ID: 34403688
[TBL] [Abstract][Full Text] [Related]
19. NMNAT1 inhibits axon degeneration via blockade of SARM1-mediated NAD
Sasaki Y; Nakagawa T; Mao X; DiAntonio A; Milbrandt J
Elife; 2016 Oct; 5():. PubMed ID: 27735788
[TBL] [Abstract][Full Text] [Related]
20. SARM1 activation triggers axon degeneration locally via NAD⁺ destruction.
Gerdts J; Brace EJ; Sasaki Y; DiAntonio A; Milbrandt J
Science; 2015 Apr; 348(6233):453-7. PubMed ID: 25908823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
